Clinical trials: Lichen Planus
Genital Lichen Planus
Treatment of Female Genital Erosive Lichen Planus(GELP) With Hexaminolevulinate PDT
To compare the effect and side effects of photodynamic treatment and traditional topical steroid treatment in female genital erosive lichen planus
- Trial name
- NCT01282515
- Testing
- clobetasol propionate 0,05% ointment, hexaminolevulinate
- Where
- Norway
- Volunteers
- 40 people
- Sponsor
- Oslo University Hospital
Oral Lichen Planus
Glucosamine as a Novel Adjunctive Therapy in Oral Lichen Planus
Glucosamine (GlcN) is an N-deacetyl amino sugar derived from the complete hydrolysis of chitosan with recently reported immunoregulatory capacity and anti-inflammatory effect and was administrated orally in osteoarthritis and…
- Trial name
- NCT02858297
- Testing
- Glucosamine sulfate, triamcinolone acetonide
- Volunteers
- 30 people
- Sponsor
- Ain Shams University
Frontal Fibrosing Alopecia, Lichen Planopilaris of Scalp
Effectiveness and Safety of Tofacitinib in Patients With Recalcitrant Frontal Fibrosing Alopecia : A Pilot Study
This study aims to determine the efficacy and safety of tofacitinib therapy in Thai patients with recalcitrant frontal fibrosing alopecia. The main questions are 1.
- Trial name
- Tofacitinib (NCT06202560)
- Testing
- Tofacitinib 5 MG
- Where
- Thailand
- Volunteers
- 11 people, healthy volunteers welcome
- Sponsor
- Institute of Dermatology, Thailand
Lichen Planus, Oral
Study of Inflammatory Role of Epstein-Barr Virus (EBV) in Atrophic and Erosive Forms of Oral Lichen Planus
Oral lichen planus (OLP) is a chronic inflammatory and relapsing. The average prevalence is 1 to 4%. The clinics forms are many and symptoms are varied.
- Trial name
- LICHENVIR (NCT02276573)
- Testing
- buccal cavity sample
- Where
- France
- Volunteers
- 13 people
- Sponsor
- Centre Hospitalier Universitaire de Nice
Lichen Planus, Oral, Lichen Planus, Mucosal
Efficacy and Safety of Baricitinib in Oral Lichen Planus: a Proof-of-Concept Study
The goal of this clinical trial is to learn the effects of baricitinib (the study drug) in patients with Oral Lichen Planus. The main questions it aims to answer are: What is the efficacy of baricitinib in treating moderate to…
- Conditions
- Lichen Planus, Oral, Lichen Planus, Mucosal, Oral Lichen Planus
- Trial name
- NCT06158113
- Testing
- Baricitinib 4 milligram Oral Tablet
- Where
- United States
- Volunteers
- 10 people
- Sponsor
- University of North Carolina, Chapel Hill
Oral Lichen Planus
Chamaemelum Nobile 2% Versus Placebo Topic Gel to Treat Oral Lichen Planus
Oral lichen planus (OLP) is a chronic inflammatory mucocutaneous disease characterized by outbreaks or flares. It affects 0.2-1.9% of the population.
- Trial name
- lichenPlanus (NCT02421770)
- Testing
- Chamaemelum nobile 2%
- Where
- Spain
- Volunteers
- 30 people
- Sponsor
- Universidad de Murcia
Oral Lichen Planus
Comparison of Triamcinolone Acetonide Mucoadhesive Film and Licorice Mucoadhesive Film Effect on Lichen Planus
Introduction :Oral lichen planus (OLP) is one of the most common disorders of the oral cavity which is basically a chronic and inflammated mucocutaneous .There is no cure for OLP currently.
- Trial name
- NCT02453503
- Testing
- Licorice, Triamcinolone Acetonide
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- Isfahan University of Medical Sciences
Lichen Planus
Implication of Human Papillomavirus (HPV) in Lichen Physiopathology in Human (HPVLichen)
Lichen planus is a chronic cutaneous and mucosal disease characterized by the infiltration of cluster of differentiation (CD) CD8 T lymphocytes, localized under the basal membrane and associated with apoptosis of basal…
- Trial name
- HPVLichen (NCT02761122)
- Testing
- Human biological samples
- Where
- 3 sites in France
- Volunteers
- 21 people
- Sponsor
- Institut Pasteur
Lichen Planopilaris
A Study of Deucravacitinib to Treat LPP and FFA
The purpose of this clinical research study is to learn more about the use of Deucravacitinib in the treatment of Lichen Planopilaris.
- Trial name
- NCT06091956
- Testing
- Deucravacitinib
- Where
- 2 sites in United States
- Volunteers
- 12 people
- Sponsor
- Mayo Clinic
Oral Lichen Planus, Oral Lichenoid Reaction
Systemic Absorption of Dexamethasone Oral Rinse in Patients With Oral Lichen Planus
The objective of this study is to see the amount of systemic absorption of a standard dose of dexamethasone oral rinse for patients with symptomatic oral lichen planus (OLP) or oral lichenoid reactions (OLR) and healthy subjects…
- Trial name
- NCT06428630
- Testing
- dexamethasone oral rinse
- Where
- United States
- Volunteers
- healthy volunteers welcome
- Sponsor
- Tufts University
Oral Lichen Planus
Evaluation of the Effectiveness of Photodynamic Therapy in the Treatment of Lesions of the Lichen Planus Type in the Oral Mucosa and Its Diagnostics With the Use of Autofluorescence, in Various Wavelength Ranges, in Combination With the Use of Texture Analysis and Fractal Dimension
Lesions of the lichen planus type within the oral mucosa are now considered a potentially cancerous condition. One of the minimally invasive methods of treating these lesions is photodynamic therapy, and the gold standard in…
- Trial name
- NCT04991012
- Testing
- PDT Therapy, Triamcinolone (Substance) therapy side
- Where
- Poland
- Volunteers
- 30 people, healthy volunteers welcome
- Sponsor
- Wroclaw Medical University
Oral Lichen Planus, Recurrent Aphthous Stomatitis
Improving Prescribing Quality for Oral Mucosal Disorders Using a Pharmacist-Led Model
This study aims to improve how oral mucosal disorders-such as oral lichen planus, recurrent aphthous stomatitis, burning mouth syndrome, herpes viral infection and oral candidiasis-are treated in dental settings.
- Conditions
- Oral Lichen Planus, Recurrent Aphthous Stomatitis, Burning Mouth Syndrome, Oral Candidiasis
- Trial name
- NCT07721090
- Testing
- Pharmacist-Led Prescribing Optimization and Patient Counselling
- Volunteers
- 336 people
- Sponsor
- University of Fujairah
Oral Lichen Planus
Oral Lichen Planus Treatment
Oral lichen planus (OLP) is a chronic inflammatory and immune-mediated disease affecting the oral mucosa. OLP presents with asymptomatic, lacelike white stripes and/or symptomatic red, ulcerated mucous membranes.
- Trial name
- NCT05127083
- Testing
- Patients will be treated with localized PBM with a diode laser
- Where
- Spain
- Volunteers
- 60 people
- Sponsor
- Universidad de Murcia
Oral Leukoplakia, Oral Leukoplakia of Tongue
Prediction of Malignant Transformation of Oral Leukoplakia Using a MAGE-A-based Immunoscore
Oral squamous cell carcinomas (OSCC) is among the most common malignancies worldwide. Early detection and prevention of OSCC is thought to have the highest potential to reduce morbidity and mortality.
- Conditions
- Oral Leukoplakia, Oral Leukoplakia of Tongue, Oral Leukoplakia of Gingiva, Oral Lichen Planus
- Trial name
- PREDICT-OLP (NCT03975322)
- Where
- Germany
- Volunteers
- 500 people
- Sponsor
- University of Erlangen-Nürnberg Medical School
Lichen Planus, Oral, Low-Level Light Therapy
Photobiomodulation in Oral Lichen Planus
The aim of this study was to compare the efficacy of PBM (660nm) and corticosteroid therapy with clobetasol propionate 0.05% in the treatment of OLP. This is a protocol for a randomized, controlled, double blind clinical trial.
- Trial name
- NCT03320460
- Testing
- Propionate clobetasol gel 0.05%, Photobiomodulation
- Where
- Brazil
- Volunteers
- 44 people
- Sponsor
- University of Nove de Julho
Atrophic Vaginitis, Vaginal Atrophy
VALOR: Vaginal Atrophy & Long-term Observation of Recovery
Vulvovaginal skin conditions, namely vaginal atrophy, lichen sclerosus, lichen simplex chronicus and lichen planus affecting the female adult population will be treated with a novel gel dressing to test the short- and long-term…
- Conditions
- Atrophic Vaginitis, Vaginal Atrophy, Genitourinary Syndrome of Menopause, Lichen Sclerosus of Vulva
- Trial name
- VALOR (NCT05953090)
- Testing
- 7-0940
- Where
- 14 sites in United States
- Volunteers
- 2,000 people
- Sponsor
- Stratpharma AG
Lichen Planus, Oral
Efficacy of Purslane in Treatment of Oral Lichen Planus
Oral lichen planus (OLP) is a chronic inflammatory disease whose prevalence in the general population is 0.5 -2.2%.Oral lesions in OLP are chronic, rarely undergo spontaneous remission.
- Trial name
- NCT00746772
- Testing
- Purslane 235mg/day in one dosage
- Where
- Iran
- Volunteers
- 37 people
- Sponsor
- Qazvin University Of Medical Sciences
Lichen Planus
Use of Injectable Platelet Rich Fibrin in Lichen Planus
Platelet Rich Fibrine (PRF), which promotes wound healing by supporting angiogenesis, immunity and epithelial proliferation phases.
- Trial name
- NCT03265093
- Testing
- Platelet Rich Fibrin Injection, Corticosteroid
- Where
- Turkey (Türkiye)
- Volunteers
- 24 people, healthy volunteers welcome
- Sponsor
- Bezmialem Vakif University
Oral Lichen Planus, Topical Sulfasalazine
Topical Sulfasalazine and Oral Lichen Planus
Oral lichen planus (OLP) is a chronic inflammatory disease that affects the mucosal membrane. T-cell mediated damage against the mucosal epithelial cells is implicated in the pathogenesis of OLP, although the exact mechanism is…
- Conditions
- Oral Lichen Planus, Topical Sulfasalazine, Corticosteroids
- Trial name
- NCT06060301
- Testing
- sulfasalazine 500 MG, corticosteroids
- Where
- Egypt
- Volunteers
- 46 people
- Sponsor
- Cairo University
Oral Lichen Planus
A Clinical Trial to Study the Effects of Two Drugs, Lycopene and Prednisolone in Patients With Oral Lichen Planus
Oral lichen planus (OLP) is a common sub-acute, chronic inflammatory mucocutaneous disease.This study was evaluated the comparative efficacy of lycopene and prednisolone for the treatment of oral lichen planus.
- Trial name
- OLP (NCT02587117)
- Testing
- lycopene, Prednisolone
- Volunteers
- 28 people
- Sponsor
- B.P. Koirala Institute of Health Sciences